Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep798 | Pituitary: clinical | ECE2015

Increased serum levels of the Wnt antagonist Dicckopf-1 (DKK1) and impaired trabecular bone mineral density using QCT scan in acromegalic patients

Valassi Elena , Crespo Iris , Aulinas Anna , Urgell Eulalia , Malouf Jorge , Llauger Jaume , Marin Ana Maria , Biagetti Betina , Webb Susan M

Introduction: Acromegaly is associated with increased bone turnover and skeletal fragility. Although the GH/IGF1 system plays an important role in bone homeostasis, effects of GH excess on the Wnt signalling pathway are to be determined. Bone quantitative CT (QCT) provides a volumetric, tridimensional measure of bone mass at the trabecular and cortical level.Aim: i) To compare volumetric bone density (vBMD) using QCT in patients with acromegaly vs gender...

ea0032p19 | Adrenal cortex | ECE2013

Genetic analysis does not confirm NCCAH in almost half of the women who had received this diagnosis: preliminary results of an audit

Alcantara Valeria , Tundidor Diana , Webb Susan , Carreras Gemma , Espinos Juan Jose , Chico Ana Isabel , Martinez Silvia , Blanco Francisco , Corcoy Rosa

Introduction: Non-classical congenital adrenal hyperplasia (NCCAH) due to 21-hydroxylase deficiency is one of the most frequent autosomal recessive diseases. Genetic analysis performed for genetic counselling revealed a miscorrelation with the clinical diagnosis in several patients at our centre.Aim: Confirm the genetic diagnosis of NCCAH in women attended for this condition.Materials and methods: Consecutive patients attended at o...

ea0016p470 | Neuroendocrinology | ECE2008

Circulating visfatin and adiponectin levels are reduced in women after long-term remission of Cushing's syndrome

Barahona Maria-Jose , Sucunza Nuria , Resmini Eugenia , Ricart Wifredo , Fernandez-Real Jose-Manuel , Rodriguez-Espinosa Jose , Webb Susan M

Metabolic syndrome and insulin resistance persist 5 years after remission of Cushing’s syndrome (CS). Adiponectin and visfatin are two adipokines highly expressed in adipose tissue. Adiponectin is reduced in obesity and insulin-resistant states; visfatin has been shown in some studies to be reduced in obesity. The aim was to evaluate visfatin and adiponectin levels, body composition, insulin resistance and prevalence of metabolic syndrome in a cohort of women with long-te...

ea0056gp139 | Neuroendocrinology | ECE2018

Why don’t corticotroph tumours always produce Cushing disease?

Garcia-Martinez Araceli , Cano David , Gil Joan , Fajardo Carmen , Camara Rosa , Lamas Cristina , Soto Alfonso , Puig Manel , Webb Susan M

Introduction: Silent corticotroph tumours (SCT) are a pituitary tumours (PT) subtype of corticotroph lineage that do not clinically express Cushing disease. Inmunohistochemical (IHC) studies reveal no differences between SCT and functioning corticotroph tumours with Cushing Syndrome (FCT). However, the silencing mechanisms of this type of tumours are not fully understood.Aim: In an important series of SCT, to sequence the POMC gene and quantify ...

ea0056p776 | Pituitary - Basic | ECE2018

Pregnancy and hypopituitarism: clinical aspects and outcome

Stantonyonge Nicole , Aulinas Anna , Garcia-Patterson Apolonia , Adelantado Jose Maria , Espinos Juan Jose , Webb Susan M , Corcoy Rosa

Introduction: Pregnancy in hypopituitary women is a rare and poorly studied clinical condition. Management difficulties and obstetrical complications have been associated with this condition.Objectives: To define the characteristics, follow-up and perinatal outcomes in hypopituitary pregnant women attended at our centre.Methods: The clinical data of the hypopituitary pregnant women (deficiency of two or more pituitary hormones), an...

ea0081ep106 | Adrenal and Cardiovascular Endocrinology | ECE2022

11-deoxycorticosterone producing adrenal hyperplasia as a very unusual cause of endocrine hypertension: case report and systematic review of the literature

Roca Queralt Asla , Simo Helena Sarda , Puertas Enrique Lerma , Hanzu Felicia Alexandra , Urgell Rull Eulalia , Perez Garcia Jose Ignacio , Youdale Susan Webb , Maso Ana Aulinas

11-deoxycorticosterone (DOC) is an aldosterone precursor synthesized from progesterone and converted to corticosterone in the adrenal cortex. DOC overproduction due to an adrenal lesion is a very rare cause of mineralocorticoid-induced hypertension. The objective of this study is to provide the most relevant clinical features that clinicians dealing with patients presenting with the hallmarks of hypertension due to DOC-producing adrenal lesions should be aware of. We report a ...

ea0063gp159 | Cushing's | ECE2019

Skeletal muscle fatty infiltration in the thigh, as assessed by MRI T2-weighted and 3-point Dixon sequences, is associated with poor performance on muscle function testing in patients with Cushing’s syndrome in remission

Martel Luciana , Alonso Alicia , Bascunana Helena , Manera Jordi Diaz , Llauger Jaume , Nunez-Peralta Claudia , Biagetti Betina , Montesinos Paula , Webb Susan , Valassi Elena

Background: Muscle weakness may persist in patients with Cushing’s syndrome (CS) long-term after resolution of hypercortisolism, but mechanisms determining this sustained impairment are not known. We hypothesized that alteration of muscle structure, due to fatty infiltration, is associated with muscle dysfunctions in these patients.Patients & methods: Twenty-six CS women [mean(±S.D.) age 49±12 years; mean(±S....

ea0049gp192 | Pituitary & endocrine Tumours | ECE2017

Long-term treatment with pegvisomant (Somavert®): Observations from 2090 acromegaly patients followed in ACROSTUDY

vanderLely Aart Jan , Biller Beverly , Brue Thierry , Buchfelder Michael , Ghigo Ezio , Pan kaijie , Jonsson Peter , Lavenberg Joanne , Strasburger Christian J. , Webb Susan , Camacho-Hubner Cecilia , Hey-Hadavi Judith

Introduction: Pegvisomant (PEGV) is approved for the treatment of acromegaly since 2003. This is the second interim analysis of data from ACROSTUDY, with the majority of patients treated for at least five years (yrs).Methods/design: ACROSTUDY is an international, open-label, prospective, non-interventional, post-marketing surveillance study monitoring the long-term safety and efficacy of PEGV. Patients were enrolled in the study on an ongoing basis.<...

ea0037gp.22.06 | Pituitary–Therapy of Cushing's disease | ECE2015

A specific nursing educational programme in patients with Cushing's syndrome

Martinez-Momblan M Antonia , Porta Nuria , Gomez Carmen , Esteve Julia , Santos Alicia , Ubeda Inmaculada , Halperin Irene , Campillo Beatriz , Guillaumet Montserrat , Webb Susan M , Resmini Eugenia

Context: Cushing’s syndrome (CS) is a rare endocrine disease, due to cortisol hypersecretion. CS patients have several comorbidities, often still present after biochemical cure. There are no specific nursing healthcare programs to address this disease and achieve improved health related quality of life (HRQoL). Thus, an educational nursing intervention in these patients, through the development and promotion of specific educational tools, appears to be justified.<p cl...

ea0035oc12.5 | Pituitary Basic | ECE2014

Does hypercortisolism of Cushing’s syndrome affect telomere length?

Aulinas Anna , Ramirez Maria Jose , Barahona Maria Jose , Valassi Elena , Resmini Eugenia , Mato Eugenia , Santos Alicia , Crespo Iris , Bell Olga , Surralles Jordi , Webb Susan

Introduction: Hypercortisolism in Cushing’s syndrome (CS) determines increased mortality and morbidity. Hypercortisolism is also present in chronic depressive disorders and stress, where telomere length (TL) is shorter than in controls. We hypothesized that telomere shortening may occur and contribute to premature morbidity in CS.Aim: Investigate TL in CS compared to matched controls, and longitudinally in a subset of CS patients evaluated both with...